Nanoscope Therapeutics Announces Presentations in Upcoming A

/PRNewswire/ -- Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today...

Related Keywords

Dallas , Texas , United States , Gainesville , Florida , University Of South Florida , Maryland , Fort Lauderdale , Baltimore , Peter Kaiser , Christine Kay , Samuel Barone , Samarendra Mohanty , Prnewswire Nanoscope Therapeutics Inc , Retina World Congress , Nanoscope Therapeutics Inc , Clinical Trials At Vitreoretinal Associates , Fort Lauderdale Marriott Harbor Beach Hotel , Therapeutics Inc , Multi Characteristic Opsin , Poster Number , Wednesday Posters , Gene Therapy Trials , Chief Medical , Non Viral Targeted Laser Delivery , Multi Characteristic Opsin Genes , Oral Abstract , Nonviral Approaches , Therapeutic Applications , Chief Scientific , Gene Therapy , Fort Lauderdale Marriott Harbor Beach , Cole Eye Institute , Cleveland Clinic Lerner College , Safety Analysis , Therapy For Retinitis Pigmentosa , Patient Case From , Assessor Masked Clinical Trial , Retinal Genetics , Clinical Trials , Vitreoretinal Associates , Affiliate Assistant Professor , Nanoscope Therapeutics ,